Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy.
Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA.
Lee IH, et al. Among authors: lee kh, lee sa, lee jl.
Korean J Intern Med. 2020 Jan;35(1):185-193. doi: 10.3904/kjim.2018.064. Epub 2018 Oct 12.
Korean J Intern Med. 2020.
PMID: 30301310
Free PMC article.